4 completed, 3 unknown, 1 terminated. 2 Not applicable, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Hematocrit: new trials by email Literature Review of Hematocrit trials Research Report on Hematocrit
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Virtual Rehabilitation in HCT Virtual exercise and rehabilitation program - Hematopoietic Cell Transplant | Not applicable | Completed | Emory University | 20 | 2023-07-31 | 2026-09-16 |
| Hematological Factors and Iron Status in Aerobic Versus Anaerobic Training in Athletic Females evaluating blood levels of hemoglobin, hematocrit, red blood cell count, mean corpuscular volume, mean corpuscular hemoglobin concentration, serum transferrin and serum ferritin. - Sports Anemia | Completed | Cairo University | 25 | 2022-09-01 | 2023-09-26 | |
| StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood Lactate, Hemoglobin, Hematocrit - Sepsis, Anemia | Terminated | Nova Biomedical | 285 | 2021-01-18 | 2021-11-11 | |
| Validation of Cardiac Magnetic Resonance Sequences in Patients With Single Ventricles Cardiac Magnetic Resonance Imaging, Blood draw for hematocrit and heart failure biomarkers, Cardiopulmonary exercise test - Single-ventricle | Unknown | Barbara Burkhardt | 63 | 2019-09-01 | 2019-07-12 | |
| Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Busulfan, Fludarabine, r-ATG - Sickle Cell Disease | Phase 2 | Completed | Medical College of Wisconsin | 138 | 2017-03-16 | 2025-04-18 |
| Prospective Clinical Study of PCV and PCV-VG in Patients Undergoing Bariatric Surgery PCV-VG, PEEP5cmH₂O, PCV, PEEP5cmH₂O - Bariatric Surgery, Mechanical Ventilation | Not applicable | Unknown | Huashan Hospital | 100 | 2017-01-16 | 2019-08-20 |
| Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas Thiotepa, Busulfan, Fludarabin - B-cell Lymphoma Refractory | Phase 2 | Unknown | Azienda Ospedaliera San Giovanni Battista | 42 | 2013-02-01 | 2014-07-08 |
| Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage Valsartan 160mg plus HCT 25mg - Hypertension, Ventricular Remodeling | Phase 4 | Completed | Federico II University | 20 | 2008-03-01 | 2009-01-29 |
Anemia (1) · Anemia, Sickle Cell (1) · Erectile Dysfunction (1) · Heart Defects, Congenital (1) · Hemorrhage (1) · Hypertension (1) · Obesity (1) · Polycythemia (1) · Sepsis (1) · Univentricular Heart (1) · Ventricular Remodeling (1)
Azienda Ospedaliera San Giovanni Battista (1) · Barbara Burkhardt (1) · Cairo University (1) · Emory University (1) · Federico II University (1) · Huashan Hospital (1) · Medical College of Wisconsin (1) · Nova Biomedical (1)
United States (3) · Italy (2) · China (1) · Egypt (1) · Switzerland (1)
Barbara EU Burkhardt, MD (1) · Benedetto Bruno, MD (1) · Brooke Lerner, PhD, FAEMS (1) · Doaa A Osman, Assis. Prof. (1) · Mary Eapen, MD (1) · Muna Qayed, MD, MsCR (1) · Serafino Fazio, MD (1) · Weimin Liang, doctor (1)
PMID 22976857, PMID 25232415, PMID 30637784, PMID 36240296, PMID 39471440
U01HL128568 (1)